Abstract Myocardial perfusion studies using dynamic contrast-enhanced cardiac magnetic resonance imaging (CMRI) could provide valuable, quantitative information regarding heart physiology in diseases such as Duchenne muscular dystrophy (DMD), that lead to diffuse myocardial damage. The goal of this effort was to develop an intuitive but physiologically meaningful method for quantifying myocardial perfusion by CMRI and to test its ability to detect global myocardial differences in a dog model of DMD. A discretetime model was developed that parameterizes contrast agent kinetics in terms of an uptake coefficient that describes the forward flux of contrast agent into the tissue, and a retention coefficient that describes the rate of decay in tissue concentration due to contrast agent efflux. This model was tested in 5 dogs with DMD and 6 healthy controls which were imaged using a perfusion sequence on a 3T clinical scanner. CINE and delayed-enhancement CMRI acquisitions were also used to assess cardiac function and the presence of myocardial scar. Among functional parameters measured by CMRI, no significant differences were observed. No myocardial scar was observed. Increased perfusion in DMD was observed with an uptake coefficient of 6.76 ± 2.41 % compared to 2.98 ± 1.46 % in controls (p = 0.03). Additionally, the retention coefficient appeared lower at 82.2 ± 5.8 % in dogs with DMD compared to 90.5 ± 6.6 % in controls (p = 0.12). A discretetime kinetic model of uptake and retention of contrast agent in perfusion CMRI shows potential for the study of DMD.
Introduction
The use of first-pass contrast-enhanced CMRI to identify myocardial perfusion deficits at rest or under stress has shown prognostic value in detecting significant coronary occlusive disease, assessing the risk of cardiovascular events, and identifying the presence of hibernating myocardium post infarct [1] [2] [3] [4] [5] [6] [7] . Perfusion CMRI studies may also provide quantitative information regarding myocardial physiology through approaches based on contrast agent kinetic modeling [8] . Such quantitative information can be especially valuable in cardiac pathologies leading to diffuse changes in myocardial properties that are too subtle to recognize based on direct inspection of the images themselves.
One potential application of quantitative perfusion CMRI is assessing the degree of cardiac involvement in Duchenne muscular dystrophy (DMD). DMD is a fatal, X-linked, recessive muscle disease caused by lack of dystrophin due to mutations in the dystrophin gene. DMD affects both skeletal and cardiac muscles [9, 10] . Due to the increasingly common use of ventilatory support, cardiomyopathy has become the leading cause of morbidity (seen in nearly all patients) and mortality (*40 %) in DMD patients [11, 12] . In addition, more than 50 % of DMD carriers also present with cardiac symptoms [11] [12] [13] . CMRI may be helpful in staging and detecting early impacts of DMD in the myocardium. In particular, perfusion CMRI may reveal vascular changes or the existence of diffuse fibrosis in the myocardium. Previous reports have shown that DMD patients exhibit a high prevalence of scar by delayed enhancement CMRI [14] [15] [16] . Perfusion studies involving PET and SPECT imaging have reported deficits in patients with DMD [17, 18] . Studies involving perfusion CMRI, however, have not been reported.
Among the challenges in applying quantitative perfusion CMRI to diseases such as DMD is the potential for global changes in perfusion that cannot be recognized as regional differences. This challenge is compounded by the lack of a concise display and simple interpretation of the quantitative results. Previous methods for quantifying perfusion CMRI results have focused either on semi-quantitative measurements, such as the upslope of the myocardial uptake curve, or kinetic models with specific physiological measurements, such as the mean transit time [8, [19] [20] [21] [22] [23] [24] . These measurements often lack a clear physiological context or else portray information that is difficult to understand by those who are not well-versed in the underlying model. Thus, the purpose of this study was twofold. First, we sought to develop an analysis approach that automatically extracts a map of perfusion characteristics and communicates the characteristics in terms of intuitive but physiologically meaningful parameters. Second, we sought to test this approach in a canine model of DMD. DMD-affected dogs represent the only animal model that faithfully mimics human DMD, reproducing many of its elements including cardiomyopathy. The affected dogs typically die from cardiac or respiratory malfunctions within 2-4 years of birth [25] , making this a meaningful preclinical model for testing out the approach.
Methods

Canine model
Research was performed according to the principles outlined in the Guide for Laboratory Animal Facilities and Care prepared by the National Academy of Sciences, National Research Council. Dogs were housed in kennels certified by the American Association for Accreditation of Laboratory Animal Care. This study was approved by the Institutional Animal Care and Use Committee of the Fred Hutchinson Cancer Research Center. All dogs were immunized for leptospirosis, distemper, hepatitis, papillomavirus and parvovirus, dewormed, and observed for disease for at least 2 months before study.
MRI protocol
All dogs were imaged with a CMRI protocol that included CINE imaging, dynamic contrast enhanced CMRI and delayed enhancement imaging. For scanning, the animals were sedated with acepromazine 0.025 mg/kg; 0.04 mg/kg/ atropine; and butorphanol 0.1-0.2 mg/kg, iv. All studies were conducted on a 3T MRI system (Philips Achieva, Best, Netherlands). CINE images were acquired with a turbo field echo (TFE) sequence that generated 30 cardiac phases for 8-10 short axis slices spanning the left ventricle. Acquisition parameters included a repetition time (TR)/echo time (TE) of 4.7/2.3 ms, a 15 degree flip angle, 4 mm slice thickness with 2 mm gaps, and an in-plane resolution of 2 mm 9 1.67 mm. The dynamic perfusion sequence was a mid-ventricle, single-slice, single-shot saturation recovery TFE acquisition with TR/TE of 3.0/1.4 ms, 20 degree flip angle, 5 mm slice thickness and in-plane resolution of 1.99 mm 9 1.96 mm. During the acquisition, 0.1 mmol/kg Gd-DTPA (Magnevist, Bayer Schering Health Care Limited, UK) was manually injected, followed by a saline flush. At 10 min after injection, three-dimensional delayed-enhancement images were acquired with an inversion-recovery TFE sequence. Acquisition parameters were TR/TE of 4/1.27 ms, 15 degree flip angle, resolution of 1.48 mm 9 1.76 mm 9 10 mm, TFE factor 24 and SENSE factor 1.5.
Kinetic model
To model the contrast agent dynamics, we used a discrete time approximation of the Kety model as previously used in perfusion CMRI [21] and given by
where K trans is the transfer constant and k ep is the transfer rate constant, C p (t) is the plasma concentration, and C t (t) is the tissue concentration. Equation 1 has also been formulated in terms of the myocardial blood flow (MBF), extraction efficiency (EE), and partition coefficient (k) [24] . The resulting equation is obtained by making the following replacements in Eq. 1:
Numerical integration of Eq. 1 under an assumption of piece-wise constant plasma concentration yields
where C p [n] and C t [n] are, respectively, the plasma and tissue concentrations in frame n of the image series,
and DT is the time step between image frames. Alternatively, this model can be written
which invites a simple interpretation of the model components. First, UC p [n] is the total forward flux of contrast agent into the tissue over one time frame. The term RC t [n -1] is the amount of contrast agent still remaining in the tissue from the previous time frame (i.e. the amount not lost to efflux). We refer to the parameters U and R as the uptake and retention, respectively. To solve for U and R, we set up the linear equation
which has a closed-form solution. Finally, to eliminate the dependence of the model parameters on DT, we normalize the results to 1-s intervals and define the uptake and retention coefficients as
Quantitative perfusion analysis
Quantitative perfusion analysis was performed by an expert in kinetic modeling (WK) with 10 years experience. The discrete kinetic model was implemented into a custom quantitative perfusion analysis package programmed in Matlab (The Mathworks, Natick, MA) and based on similar analysis tools for perfusion analysis of artery wall images [26, 27] . In this program, a time series of frames was extracted from the dynamic sequence starting at the frame immediately before bolus arrival in the right ventricle and ending 30 s later. The frame with approximately maximal enhancement of the left ventricle chamber was also identified. Then, an automatic registration algorithm [26] was run in both directions from the frame of maximal enhancement within an 8.75 cm 9 8.75 cm region of interest centered on the left ventricle. Each frame was matched to the previous one by identifying the in-plane shift that minimized the sum of the square roots of the absolute differences between pixel values. Next, an automatic arterial input function (AIF) extraction algorithm [27] was used to identify an enhancement-versustime curve representing the blood within the left ventricle chamber. Enhancement-versus-time curves were extracted from all pixels within a 7-pixel 9 7-pixel region at the center of the chamber. For each pixel, all pixels with similar curves were identified via a mean shift algorithm, and the mean curve for those pixels was found. The AIF was identified as the mean curve based on at least 5 pixels, with maximal enhancement.
Finally, maps of the uptake and retention coefficients were computed for every pixel within the region of interest using Eq. 4. Concentration was assumed to be proportional to the change in signal intensity. In addition, an average tissue curve for the entire myocardium was extracted by averaging all pixels within manually drawn epicardial and endocardial boundaries. The model parameters were then extracted from this average curve to obtain a single overall value for the myocardium. For the overall value, model parameters were obtained from the non-linear Eq. 2 using a gradient descent algorithm with R constrained to be less than or equal to 100 %. The non-linear formulation was found to yield less fitting error than Eq. 4 for quantitative analyses.
Cardiac functional analysis
In addition to the perfusion analysis, functional parameters were computed from the CINE images using a ViewForum Workstation (Philips, Best, Netherlands). Epicardial and endocardial boundaries of the left ventricle were interactively traced at end-diastole and end-systole by an expert (AN) with 9 years experience in cardiac analysis. Based on the boundaries, the following measurements were obtained: end-systolic volume (ESV), end-diastolic volume (EDV), stroke volume (SV), ejection fraction (EF), cardiac output (CO), and left ventricular mass (LVM). Finally, delayed enhancement CMRI results were qualitatively assessed for the presence of focal areas of enhancement.
Data analysis
Comparisons between measurements from DMD dogs and normal controls were assessed by two-sided Student's t-tests. P-values less than 0.05 were considered statistically significant.
Results
The study involved 5 dogs with DMD and 6 normal controls. Ages for dogs with DMD averaged 41 ± 38 months (range 12-98) and weight averaged 14.33 ± 1.8 kg (range 11.7-16.5 kg). Healthy controls had mean age 20 ± 4 months (range 15-25) and weight averaged 12.2 ± 3.26 kg (range 9.3-16.3 kg). All DMD dogs were confirmed by genotyping and increased serum creatine kinase level. Clinical signs of the disease varied among the 5 dogs. While the 3 younger DMD-affected dogs (aged 12, 13 and 17 months) showed obvious clinical symptoms, including difficulties in eating, walking and breathing, the two older affected dogs (aged 5 years 2 months, and 8 years 2 months) were in generally good health.
Cardiac functional parameters for dogs with DMD and healthy controls are summarized in Table 1 . No significant differences in functional parameters were observed other than dogs with DMD having higher heart rates compared to normal controls (170 versus 111 bpm, p = 0.01). Although not significantly different, EF tended to be lower in dogs with DMD. Of the 5 dogs exhibiting EF \ 55 %, 4 (80 %) were from the DMD group. Comparisons of end-diastolic and end-systolic images from dogs with DMD and normal controls are shown in Fig. 1 . The statistical comparison of EF was impacted by an outlying value from a dog with DMD that exhibited the highest EF (71.4 %) and was by far the oldest in the study at more than 8 years. Without this dog, the difference in EF approached statistical significance (p = 0.06). Finally, no evidence of focal delayed enhancement was observed in any dogs, indicating a lack of identifiable infarcted tissue. Perfusion analysis was successfully performed for all dogs with DMD and 5 (83 %) healthy controls. In the one remaining healthy control, weak enhancement was observed within the chamber, but no measurable tissue enhancement was seen. This was attributed to partial failure of the injection and this dog was excluded from further analysis.
In the remaining dogs, visual evaluation confirmed that the automatic registration algorithm effectively eliminated translational motion due to breathing. The AIF extraction algorithm generated similar curves for all dogs, consisting of a fast-rising first peak followed by a second smaller peak due to bolus recirculation. The model produced qualitatively excellent fit results for the average myocardial enhancement curve (Fig. 2) . Average values of U 1 sec and R 1 sec for both groups are plotted in Fig. 3 . Dogs with DMD exhibited significantly higher uptake with mean U 1 sec (±standard deviation) of 6.76 % (±2.41 %) compared to 2.98 % (±1.46 %) in controls (p = 0.03). Additionally, retention appeared lower with mean R 1 sec of 82.2 % (±5.8 %) in dogs with DMD compared to 90.5 % (±6.6 %) in controls (p = 0.12).
Representative perfusion maps of the uptake and retention coefficients are shown in Fig. 4 for a dog with DMD and a healthy control. Maps of both U 1 sec and R 1 sec show fairly uniform values within the myocardium, which is easily distinguished from surrounding regions. These examples confirm on a pixel scale the observed tendency for higher uptake and reduced retention in dogs with DMD. We also observe that the left ventricle chamber is characterized by 100 % uptake and 0 % retention. The right ventricle chamber, on the other hand, exhibits a nonphysical model result with 0 % uptake and 100 % retention. This is attributed to the time lag between bolus arrival in the right and left ventricles, which is not captured in the model.
Discussion
This study illustrates the potential utility of a discrete approximation of the Kety model for quantitative perfusion analysis by CMRI. By parameterizing the model in terms of uptake and retention coefficients, perfusion maps are presented in an intuitive representation of the rates of wash-in and wash-out, respectively. Using this framework, the clinician can quickly assess whether abnormal contrast enhancement is due to altered delivery of the agent, increased retention of the agent, or both. On the other hand, a direct relationship exists between U 1 sec and R 1 sec and the kinetic parameters K trans , k ep , MBF, EE, and k. This permits the discrete parameters to be translated into those more traditional physiological quantities.
The application of this technique to a study of DMD in dogs demonstrated its ability to reliably and automatically extract qualitative and quantitative representations of cardiac perfusion. Few prior studies of contrast agent uptake in DMD exist. A study in skeletal muscle in a mouse model found that early in the disease, enhanced perfusion is likely due to active degeneration/regeneration processes in muscle, with reduced perfusion in later stages of the disease [28] . In humans, a high prevalence of myocardial scar has been observed which typically is associated with perfusion deficits [14] [15] [16] . In this study, no myocardial scar was observed; however, it does not exclude ongoing inflammation or fibrosis. Because of the lack of scar and enhanced perfusion in dogs with DMD, our results are consistent with an early-stage disease model. If confirmed in further studies, this finding could have implications for studies relating perfusion responses to treatment in dogs versus humans. A major motivation for this study was a desire to use this technique in the future to monitor changes in cardiac function over time for disease staging or monitoring therapy, first in the preclinical DMD dogs and then translating into human DMD patients. Whether myocardial perfusion transitions from a hyperperfused state to a hypoperfused state in later stages of DMD remains to be determined. In principle, the technique described here provides a robust, automated, and quantitative approach to address such questions.
In addition to investigating myocardial perfusion in DMD, this study also examined quantitative cardiac function based on cross-sectional CINE images. Reduced EF has been frequently observed in echocardiographic studies of DMD [29] [30] [31] . The results here indicated a trend toward reduced EF in dogs with DMD. We also observed elevated heart rates within the DMD group. One question that arises is whether the apparent changes in perfusion observed are a consequence or contributing cause of the altered functional parameters. Investigating this question will prove critical in determining which parameters are of most value for assessing cardiac involvement in DMD.
Regarding the discrete kinetic model implementation, insight can be gained by considering a hypothetical case in which the AIF rises to a concentration C for one time interval before returning to zero. In this case, the tissue concentration would rise to UC over the interval and then decay at a rate proportional to R t . In actual situations, the contrast agent kinetics can be viewed as the superposition of such impulse responses due to the concentration in each interval [8] . From this, we see that two aspects of contrast agent dynamics are neglected in the model. First, changes in the AIF over the interval are not modeled, and second, the model does not account for any contrast agent that Fig. 4 Parametric maps of the uptake coefficient (left) and retention coefficient (right) for a dog with DMD (top) and a health control (bottom) enters and leaves the tissue within the same interval. The impact of both of these assumptions is minimized by using short intervals, such as single heart beats. In this study, the interval was typically on the order of 0.5 s.
In this study, we also explored two methods for fitting the model to the data. For producing parametric images, we used the linear solution of Eq. 4, which could be rapidly computed for every pixel in the image. The results, however, were not as accurate as those from direct fitting of Eq. 2 because the presence of tissue concentrations on both sides of Eq. 4 can lead to numerical instabilities. The differences were not apparent when viewing parametric images, but for quantitative reporting, we chose to use nonlinear fitting of Eq. 2.
The major limitation for this study is its small size. In many cases, compelling trends were observed, such as the reduced retention coefficient in dogs with DMD, but did not achieve statistical significance. The small size also precluded multiparametric analyses to assess interactions between variables. Most notably, the influence of the larger distribution in ages of the dogs with DMD compared to the healthy controls was not assessed. Nevertheless, the small study size was sufficient to demonstrate the potential of this approach for future studies.
In conclusion, this study illustrates the potential utility of a discrete model of contrast agent kinetics to investigate myocardial perfusion characteristics. Model parameters describing uptake and retention of the contrast agent were automatically extracted in all cases on a pixel level. When applied to the study of DMD in dogs, the model was consistent with enhanced perfusion associated with the disease.
